Evolving Partnerships: Academia, Pharma and Venture Groups Adapt to Challenging Times
from Science Direct
Several times a week, Markus Frank, Assistant Professor of Pediatrics at Harvard Medical School, meets with scientists from Pfizer, with whom he is collaborating. Their mutual goal, which joins Frank and a postdoc with Pfizer antibody engineers, toxicologists and other skilled hands, is to further develop a strategy for targeting stem cells in malignant melanoma that Frank has worked on for six years. There's no need to commute to the pharmaceutical giant's R&D facilities or connect through Skype. Face-to-face meetings can even happen spur-of-the-moment, since Pfizer's Boston-based Center for Therapeutic Innovation (CTI) is directly across Longwood Avenue from Frank's lab.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063